PRI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
PRI is not a good buy right now for an impatient investor. Despite strong recent fundamentals and heavy hedge-fund accumulation, the technical trend is still bearish (stacked moving averages and negative MACD). With no proprietary Intellectia buy signals today and earnings coming (2026-02-11 AH), the risk/reward for buying immediately at ~$261 is only moderate. A better “must-act-now” stance is to hold/avoid chasing until price strength returns (reclaiming ~268–272) or it offers a cleaner discount closer to ~255 support.
Trend/structure: Bearish. Moving averages are stacked bearishly (SMA_200 > SMA_20 > SMA_5), implying the bigger trend remains down despite the stock holding near the pivot (~261.5). Momentum: MACD histogram is negative (-0.538) but contracting, which hints downside momentum is fading—not yet a confirmed reversal. RSI: RSI(6) ~57.7 (neutral-to-slightly-positive), not oversold and not screaming “buy the dip.” Key levels: Pivot 261.5. Support S1 ~255.1 (then S2 ~251.2). Resistance R1 ~267.9, R2 ~271.8. For a fast entry, buying below pivot with bearish MA stack is less attractive; a breakout above ~268 would improve the setup.
Intellectia Proprietary Trading Signals
Strong recent operating momentum: 2025/Q3 revenue +8.49% YoY, net income +25.86% YoY, EPS +31.47% YoY.
Hedge funds are buying aggressively (reported +2734.84% increase in buying amount over the last quarter), suggesting institutional accumulation.
Earnings catalyst ahead: QDEC 2025 earnings on 2026-02-11 (AH) could re-rate the stock if results/guide impress.
Bullish analyst anchor: TD Cowen reiterated Buy and raised PT to $326 (2026-01-28).
Technicals still bearish (SMA_200 > SMA_20 > SMA_5 and MACD below zero), which often caps near-term upside for immediate entries.
Analyst consensus tone is mixed: multiple firms kept neutral-ish stances (Equal Weight/Market Perform) and lowered price targets recently.
Options imply elevated uncertainty (IV percentile
into the next catalyst window.
No supportive near-term news flow in the past week to act as an immediate upside trigger.
Latest reported quarter: 2025/Q3. Growth was strong: Revenue $839.852M (+8.49% YoY), Net Income $206.115M (+25.86% YoY), EPS $6.35 (+31.47% YoY). The trend shows accelerating profitability versus revenue growth (earnings leverage), which is fundamentally supportive even if the chart has not fully turned yet.
Recent trend: mixed to slightly cautious overall. TD Cowen (2026-01-28) raised PT to $326 and stayed Buy, but Morgan Stanley lowered PT twice (to $301 then $292) while keeping Equal Weight, and Keefe Bruyette lowered PT to $315 while keeping Market Perform. Wall Street pros: Strong EPS momentum and a clear Buy-rated bull case (TD Cowen) with meaningful upside to PT. Wall Street cons: Multiple neutral ratings and PT cuts tied to macro/returns headwinds; overall tone suggests “good company, less compelling near-term setup.” Influential/political trading check: No recent congress trading data available in the last 90 days; insider trend is reported as neutral (no significant recent insider trading trend).
